文献速递腹部CT

双能CT定量肝脏细胞外容积分数预测肝硬化患者肝脏相关事件

Quantification of liver extracellular volume using dual-energy CT: utility for prediction of liver-related events in cirrhosis.
PubMed 文献 · Eur Radiol · 2020-04-26

本回顾性研究纳入305例肝硬化患者,利用双能CT平衡期碘图测量肝脏细胞外容积分数(fECV),发现fECV评分与基线失代偿独立相关,并可独立预测代偿期肝硬化患者的肝脏相关事件;基于fECV评分和白蛋白水平的风险分层模型可区分不同风险组。

要点

  • 双能CT平衡期碘图测量的fECV评分与肝硬化基线失代偿独立相关(OR 1.27)。
  • fECV评分可独立预测代偿期肝硬化患者的肝脏相关事件(HR 1.40)。
  • fECV评分联合血清白蛋白水平构建的风险模型可将患者分为不同风险组。

核心结论

  • 双能CT碘图衍生的fECV评分可预测肝硬化患者的肝脏相关事件。

研究设计与样本

  • 回顾性研究,纳入305例肝硬化患者,均接受双源双能CT成像并在初次CT检查2周内完成血清标志物分析;fECV评分通过注射对比剂后3分钟平衡期图像(100/140 Sn kVp)的碘图测量。

诊断标准与关键数值

  • fECV评分以27%为界值(<27% versus ≥27%),血清白蛋白以4 g/dL为界值(<4 versus ≥4 g/dL)构建风险模型;fECV评分与基线失代偿独立相关(OR 1.27,95%CI 1.15–1.40);在代偿期肝硬化患者中,fECV评分(HR 1.40,95%CI 1.22–1.62)和血清白蛋白水平(HR 0.26,95%CI 0.09–0.73)为LRE的独立预测因子。

临床应用与阅片要点

  • 作者建议将双能模式平衡期扫描作为肝硬化患者肝脏CT检查的一部分,因其可提供LRE发生的预后指标。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To determine whether quantification of liver extracellular volume fraction (fECV) using dual-energy CT (DECT) allows prediction of liver-related events (LREs) in cirrhotic patients.

METHODS: This retrospective study included 305 cirrhotic patients who underwent dual-source DECT imaging and had serum markers analyzed within 2 weeks of initial CT imaging. The fECV score was measured using an iodine map of equilibrium-phase images obtained 3 min after contrast injection at 100/140 Sn kVp. The association of the fECV score and serum markers with LREs was investigated. A risk model combining the fECV score (< 27 versus ≥ 27%) and serum albumin level (< 4 versus ≥ 4 g/dL) was constructed for LRE prediction.

RESULTS: An increased fECV score (odds ratio, 1.27; 95% confidence interval (CI), 1.15, 1.40) was independently associated with decompensated cirrhosis at baseline (n = 85) along with the Model for End-Stage Liver Disease score (odds ratio, 1.32; 95% CI, 1.07, 1.63). Among patients with compensated cirrhosis, 10.5% (23 of 220) experienced LREs during the median follow-up period of 2.0 years (decompensation, n = 14; hepatocellular carcinoma, n = 9). The fECV score (hazard ratio, 1.40; 95% CI, 1.22, 1.62) and serum albumin level (hazard ratio, 0.26; 95% CI, 0.09, 0.73) were independent predictors of LRE. The mean times to LRE among the high (16.5 months, n = 18)-, intermediate (25.6 months, n = 44)-, and low (30.5 months, n = 158)-risk groups were significantly different (p < 0.001).

CONCLUSIONS: The fECV score derived from DECT allows prediction of LREs in cirrhotic patients.

KEY POINTS: • The extracellular volume fraction (fECV) score derived from the iodine map of dual-energy CT (DECT) was independently associated with the presence of hepatic decompensation. • The fECV score derived from the iodine map of DECT can predict liver-related events (LREs) in patients with cirrhosis. • Equilibrium-phase scanning in dual-energy mode is recommended as part of liver CT in cirrhotic patients because it can provide a prognostic indicator for LRE development.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Bak S, Kim JE, Bae K, et al. Quantification of liver extracellular volume using dual-energy CT: utility for prediction of liver-related events in cirrhosis. Eur Radiol. 2020. PMID: 32335746. doi:10.1007/s00330-020-06876-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。